KEVIN D. FREEMAN - 19 Jan 2022 Form 4/A - Amendment Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
19 Jan 2022
Net transactions value
+$9,806
Form type
4/A - Amendment
Filing time
19 Jan 2022, 10:18:30 UTC
Date Of Original Report
19 Jan 2022
Previous filing
15 Dec 2021
Next filing
25 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Purchase $9,806 +5,000 +10% $1.96 55,000 19 Jan 2022 By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC F1
holding GALT Common Stock 23,469 19 Jan 2022 Direct
holding GALT Common Stock 16,000 19 Jan 2022 IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.